Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 29, 2013
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial
B W Bode, J B Buse, M Fisher, et al.
Clinical Biochemistry
|
December 25, 2012
Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis
Miriam J Smith, Sonia Esparza, Vanessa L Merker, et al.
Familial Cancer
|
December 16, 2025
"It's not any one thing, it's always all of them, all at the same time": quality of life in NF2-related schwannomatosis from patient and clinician perspectives
Sophia C Carias, Frank D Buono, Liesel Von Imhof, et al.
Contemporary Clinical Trials
|
August 29, 2022
Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain
Jennifer L W Da, Vanessa L Merker, Justin T Jordan, et al.
Clinical Trials (London, England)
|
November 14, 2023
Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
Pamela L Wolters, Nour Al Ghriwati, Melissa Baker, et al.
Social Science & Medicine (1982)
|
July 16, 2021
"Because the country, it seems though, has turned their back on me": Experiences of institutional betrayal among veterans living with Gulf War Illness
Katharine Bloeser, Kelly K McCarron, Vanessa L Merker, et al.
Plos One
|
May 5, 2012
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis
Scott R Plotkin, Miriam A Bredella, Wenli Cai, et al.
Developmental Medicine and Child Neurology
|
December 5, 2012
Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach
Agnies M van Eeghen, Margaret B Pulsifer, Vanessa L Merker, et al.
JAMA Network Open
|
October 17, 2025
Coherence of Stroke Survivors' Lived Experiences and the Stroke-Specific Quality of Life Scale
Devanshi Choksi, Mary Craven, Taylor McVeigh, et al.
American Journal of Medical Genetics. Part A
|
September 18, 2021
Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey
Pamela L Wolters, Stephanie Reda, Staci Martin, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 29, 2013
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial
B W Bode, J B Buse, M Fisher, et al.
Clinical Biochemistry
|
December 25, 2012
Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis
Miriam J Smith, Sonia Esparza, Vanessa L Merker, et al.
Familial Cancer
|
December 16, 2025
"It's not any one thing, it's always all of them, all at the same time": quality of life in NF2-related schwannomatosis from patient and clinician perspectives
Sophia C Carias, Frank D Buono, Liesel Von Imhof, et al.
Contemporary Clinical Trials
|
August 29, 2022
Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain
Jennifer L W Da, Vanessa L Merker, Justin T Jordan, et al.
Clinical Trials (London, England)
|
November 14, 2023
Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
Pamela L Wolters, Nour Al Ghriwati, Melissa Baker, et al.
Social Science & Medicine (1982)
|
July 16, 2021
"Because the country, it seems though, has turned their back on me": Experiences of institutional betrayal among veterans living with Gulf War Illness
Katharine Bloeser, Kelly K McCarron, Vanessa L Merker, et al.
Plos One
|
May 5, 2012
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis
Scott R Plotkin, Miriam A Bredella, Wenli Cai, et al.
Developmental Medicine and Child Neurology
|
December 5, 2012
Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach
Agnies M van Eeghen, Margaret B Pulsifer, Vanessa L Merker, et al.
JAMA Network Open
|
October 17, 2025
Coherence of Stroke Survivors' Lived Experiences and the Stroke-Specific Quality of Life Scale
Devanshi Choksi, Mary Craven, Taylor McVeigh, et al.
American Journal of Medical Genetics. Part A
|
September 18, 2021
Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey
Pamela L Wolters, Stephanie Reda, Staci Martin, et al.
Page
of 8